19th International Conference of Drug Regulatory Authorities
28 September - 2 October 2020
Hotel Le Méridien, New Delhi, India

Namaste! Greetings from India!

The Ministry of Health & Family Welfare (MoHFW), Government of India, along with WHO welcomes the participants and delegates of the "19th International Conference of Drug Regulatory Authorities (ICDRA), New Delhi, India, 28th September- 2nd October 2020”.

The 2030 Agenda for Sustainable Development is an ambitious global agenda. Sustainable Development Goal 3 (SDG 3) - Good Health and Well-being aims at ensuring healthy lives and promote well-being for all at all ages. Health finds mention in many of the 17 SDGs; each has a direct or indirect bearing on health. Therefore, diverse capacities are required to achieve the SDG aspirations. WHO’s 13th Global Programme of Work (GPW13) provides strategic direction for achieving SDG 3 and contributing to the 2030 Agenda for Sustainable Development.

Read More..

Dr Harsh Vardhan

Union Minister, Ministry of Health and Family Welfare, Science and Technology and Earth Sciences, Government of India

Theme of 19th International Conference of Drug Regulatory Authorities

Smart Regulation: Delivering Quality Assured Medical Products for All

This year’s theme: Smart Regulation: Delivering Quality Assured Medical Products for All  is closely aligned with WHO’s 2019–2023 plan to help build effective and efficient regulatory systems and is designed to assist national regulators to deliver regulation that protects the public while enabling timely access to quality products and encouraging innovation. This theme prioritizes regulatory initiatives to help our Member States increase access to universal health coverage (UHC), support health emergency responses, and promote healthier populations.

WHO has been playing a vital role in terms of improving regulation to provide a platform for regulators to discuss common challenge and identify areas where further guidance for regulators need to be developed. The WHO has convened the International conference of drug regulatory authorities (ICDRA) every 2 years since 1980. The 19 th International Conference of Drug Regulatory Authorities (ICDRA) will be hosted in New Delhi, India from 28th September- 2nd October 2020.

The ICDRAs have been instrumental in guiding regulatory authorities, WHO and interested stakeholders and in determining priorities for action in national and international regulation of medical products. As a platform established to develop international consensus, the ICDRA continues to be an important tool for WHO and drug regulatory authorities in their efforts to improve the safety, efficacy and quality of medical products.

Welcome to the 19th International Conference of Drug Regulatory Authorities

The Central Drugs Standard Control Organization is honoured to host the 19th ICDRA and to welcome fellow regulators and leading international stakeholders to participate in one of the largest global gatherings for medical products regulation. The theme of 19th ICDRA is Smart Regulation: Delivering Quality Assured Medical Products for All. This theme prioritizes regulatory initiatives to help our Member States increase access to universal health coverage (UHC), support health emergency responses, and promote healthier populations.

Ms Preeti Sudan

Health Secretary, Ministry of Health and Family Welfare, Government of India

Dr V. G. Somani

Drugs Controller General of India

Introduction

Regulatory authorities are continually faced with new issues - such as globalization and extension of free trade - while increased responsibilities from expansion of the market and the improvement and sophistication of products place heavy demands on regulatory systems and knowledge bases. The development of cutting edge technologies and health care techniques and extensive use of the Internet impose further complex challenges.

The International Conference of Drug Regulatory Authorities (ICDRAs) provide drug regulatory authorities of WHO Member States with a forum to meet and discuss ways to strengthen collaboration. The conferences have been held biennially since 1980 with the aim of promoting exchange of information and collaborative approaches to issues of common concern related to regulation of medical products.

Background of the Conference

The International Conference of Drug Regulatory Authorities (ICDRAs) provide drug regulatory authorities of WHO Member States with a forum to meet and discuss ways to strengthen collaboration. The conferences have been held since 1980 with the aim of promoting exchange of information and collaborative approaches to issues of common concern.

The recommendations from previous conference can be accessed at:

https://www.who.int/medicines/areas/quality_safety/regulation_legislation/icdra/en/

Read more..